TrialHuman vaccines & immunotherapeutics2014
A phase 2 randomized controlled trial of a multicomponent meningococcal serogroup B vaccine (I).
Roman Prymula et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
34 papers cite it
this paperpooled ittrialcites it